"Interleukin-13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
    
    
        
            
            
                A cytokine synthesized by T-LYMPHOCYTES that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-LYMPHOCYTES. It appears to play a role in regulating inflammatory and immune responses.
    
            
            
                
                    
                        
                            | Descriptor ID | 
                            
                                D018793
                             | 
                        
                        
                            | MeSH Number(s) | 
                            
                                 D12.644.276.374.465.513 D12.776.467.374.465.513 D23.529.374.465.513 
                             | 
                        
                        
                            | Concept/Terms | 
                            
                                
                             | 
                        
                    
                
             
            
                Below are MeSH descriptors whose meaning is more general than "Interleukin-13".
                
             
            
            
                Below are MeSH descriptors whose meaning is more specific than "Interleukin-13".
                
             
         
     
 
                                            
                                                
	
	
		
			
			
					
				This graph shows the total number of publications written about "Interleukin-13" by people in this website by year, and whether "Interleukin-13" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1999 | 0 | 1 | 1 | 
| 2000 | 1 | 1 | 2 | 
| 2010 | 1 | 2 | 3 | 
| 2011 | 1 | 1 | 2 | 
| 2014 | 0 | 1 | 1 | 
| 2016 | 1 | 0 | 1 | 
| 2017 | 7 | 19 | 26 | 
| 2018 | 6 | 9 | 15 | 
| 2019 | 3 | 4 | 7 | 
| 2020 | 0 | 1 | 1 | 
| 2021 | 0 | 1 | 1 | 
                   To return to the timeline, click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Interleukin-13" by people in Profiles.
						
					
								- 
								
IL-13 is a driver of COVID-19 severity. JCI Insight. 2021 08 09; 6(15).
															
								 
							
								- 
								
SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat Rev Immunol. 2021 04; 21(4):202-203.
															
								 
							
								- 
								
IL-4/IL-13 remodeling pathway of COVID-19 lung injury. Sci Rep. 2020 10 29; 10(1):18689.
															
								 
							
								- 
								
Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020 10 12; 11(1):5139.
															
								 
							
								- 
								
COVID-19 and Asthma: Reflection During the Pandemic. Clin Rev Allergy Immunol. 2020 Aug; 59(1):78-88.
															
								 
							
								- 
								
Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020 08; 584(7821):463-469.
															
								 
							
								- 
								
Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020 Jul; 146(1):80-88.e8.
															
								 
							
								- 
								
Increased type 2 inflammation post rhinovirus infection in patients with moderate asthma. Cytokine. 2020 01; 125:154857.
															
								 
							
								- 
								
Impact of ART on dynamics of growth factors and cytokines in primary HIV infection. Cytokine. 2020 01; 125:154839.
															
								 
							
								- 
								
Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis. Cytokine. 2020 01; 125:154799.